Clinical Trial Update: Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial is assessing whether peri-operative tamsulosin improves voiding trials after same-day urogynecology surgery; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Urinary Retention

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: TriHealth Inc. | Conditions: Postoperative Urinary Retention (POUR) | Phase 3 | Status: RECRUITING